BioCentury

7:00 AM GMT, Jul 28, 2003
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Product Development

Roche's product deal flow

Roche's product deal flow

Date Partner Disease area Status at time of deal Deal
4/9/02 Isotechnika (TSE:ISA) Autoimmune/Inflammation, Transplant Ph II Will co-develop ISA's ISA247, a calcineurin inhibitor immunosuppressant in Phase

Read the full 314 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.